Opinion
Video
Author(s):
Jenny Murase, MD, describes how rising estrogen levels cause a shift in immune response from Th1 to Th2, causing potential atopic dermatitis exacerbations for patients who are pregnant.
Dupilumab in Hyper-IgE Syndrome: A Case Series of Pediatric Patients
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Experts Delve Into Upadacitinib vs Dupilumab: Insights From LEVEL UP
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAAD